An esterase-activated celastrol delivery system suppressed steatosis-related hepatocellular carcinoma progression
Biomaterials Science · 2026 · 14 (15) · 3982-3994
DOI: 10.1039/d6bm00447d ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Science, 2026. Verfasst von Zile Shao und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou 310053, China. qiunasha@zju.e…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Pentacyclic Triterpenes, Fatty Liver. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province.
Abstract (Originalsprache)
Schematic illustration of intratumorally delivered PQDMA@CEL NPs, triggering HCC ferroptosis and degrading lipids, and further remodeling immunosuppressive microenvironment and enhancing anti-tumor efficacy in Hepa1-6 bilateral tumor models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou 310053, China. qiunasha@zju.edu.cn.
- Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310006, China.
- Zhejiang University School of Medicine, Hangzhou 310058, China.
- Hangzhou Normal University, Hangzhou 311121, China.
- Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Key Research and Development Program of Zhejiang Province
Zitieren
APA
Shao, Z., Xie, Y., Shen, Y., Sun, Y., Zhang, L., Qiu, N., & Xu, X. (2026). An esterase-activated celastrol delivery system suppressed steatosis-related hepatocellular carcinoma progression. Biomaterials Science, 14(15), 3982-3994. https://doi.org/10.1039/d6bm00447d
Vancouver
Shao Z, Xie Y, Shen Y, Sun Y, Zhang L, Qiu N, et al. An esterase-activated celastrol delivery system suppressed steatosis-related hepatocellular carcinoma progression. Biomaterials Science. 2026;14(15):3982-3994. doi:10.1039/d6bm00447d
BibTeX
@article{Shao2026,
author = {Shao, Zile and Xie, Yangla and Shen, Yidan and Sun, Yiyang and Zhang, Long and Qiu, Nasha and Xu, Xiao},
title = {An esterase-activated celastrol delivery system suppressed steatosis-related hepatocellular carcinoma progression},
journal = {Biomaterials Science},
year = {2026},
volume = {14},
number = {15},
pages = {3982--3994},
doi = {10.1039/d6bm00447d}
}
EUVIMED